• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[尿细菌对头孢布烯的形态学反应]

[Morphological response of urinary bacteria to ceftibuten].

作者信息

Washida H, Sakagami H, Awata S, Kan K, Kawai N, Inuzuka K

机构信息

Washida Clinic.

出版信息

Jpn J Antibiot. 1996 Mar;49(3):273-8.

PMID:8935123
Abstract

UNLABELLED

The morphological response of urinary Gram-negative bacteria to ceftibuten (CETB) was investigated in four patients with urinary tract infections (one patient: acute uncomplicated cystitis, three patients: chronic complicated urinary tract infection). The daily dose of CETB was 400 mg administered orally and the durations were 3 days for the acute uncomplicated cystitis case and 5 days for the chronic complicated urinary tract infection cases. In the four patients, changes in urinary CETB concentrations, viable bacterial counts, and morphology of the bacteria were studied after the initial administration. The urinary concentrations of CETB were 7.38-60.3 micrograms/ml at one hour after the first administration. The urinary viable cell counts were 1-5 x 10(7) cells/ml before administration, but they were reduced to 1-3 x 10(3) cells/ml at one hour after the first oral administration. Morphological changes of bacteria: Under phase contrast microscopy, filamentous debris and spherical bacteria with severe body damage were observed at 30 minutes after the first administration. By transmission electron microscopy, the cell wall of the filamentous bacteria showed a number of projections with formation of vacuolar structures in the space between the cell wall and the irregularly-shaped cytoplasm. According to the Japanese UTI criteria, the efficacy rate was 100% in the 4 patients. Neither side effect nor abnormal laboratory result was observed in any patient.

CONCLUSION

The morphological changes of the bacteria suggested that CETB, in vivo, bounds not only penicillin-binding protein (PBP)-3 but also PBP-1.

摘要

未标记

对4例尿路感染患者(1例:急性单纯性膀胱炎,3例:慢性复杂性尿路感染)研究了尿中革兰氏阴性菌对头孢布烯(CETB)的形态学反应。CETB的日剂量为400mg口服,急性单纯性膀胱炎病例疗程为3天,慢性复杂性尿路感染病例疗程为5天。在这4例患者中,研究了首次给药后尿中CETB浓度、活菌计数及细菌形态的变化。首次给药后1小时尿中CETB浓度为7.38 - 60.3微克/毫升。给药前尿中活菌计数为1 - 5×10⁷个细胞/毫升,但首次口服给药后1小时降至1 - 3×10³个细胞/毫升。细菌的形态学变化:在相差显微镜下,首次给药后30分钟观察到丝状碎片和菌体严重受损的球形细菌。通过透射电子显微镜观察,丝状细菌的细胞壁显示出许多突起,在细胞壁与不规则形状的细胞质之间的空间形成了空泡结构。根据日本尿路感染标准,4例患者的有效率为100%。所有患者均未观察到副作用或实验室检查结果异常。

结论

细菌的形态学变化表明,CETB在体内不仅与青霉素结合蛋白(PBP)-3结合,还与PBP-1结合。

相似文献

1
[Morphological response of urinary bacteria to ceftibuten].[尿细菌对头孢布烯的形态学反应]
Jpn J Antibiot. 1996 Mar;49(3):273-8.
2
[Clinical studies and morphological response on ST-95 (fosfomycin)].
Hinyokika Kiyo. 1991 Mar;37(3):321-6.
3
[Clinical experience with ceftibuten in complicated urinary tract infections].
Jpn J Antibiot. 1990 May;43(5):779-89.
4
[Clinical studies on ceftibuten in the urinary field infection].
Jpn J Antibiot. 1990 Nov;43(11):2003-10.
5
[Clinical studies of ceftibuten in the field of urology].
Jpn J Antibiot. 1990 Feb;43(2):355-61.
6
Comparative study of ceftibuten and cefixime in the treatment of complicated urinary tract infections.头孢布烯与头孢克肟治疗复杂性尿路感染的对比研究。
J Microbiol Immunol Infect. 2001 Sep;34(3):185-9.
7
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.将他唑巴坦-哌拉西林与舒巴坦-氨苄西林、克拉维酸-替卡西林、舒巴坦-头孢哌酮及哌拉西林进行比较,观察其对从复杂性尿路感染患者中分离出的产β-内酰胺酶细菌的抗菌活性。
J Chemother. 1997 Apr;9(2):89-94. doi: 10.1179/joc.1997.9.2.89.
8
Treatment of acute uncomplicated urinary tract infection with ceftibuten.用头孢布烯治疗急性单纯性尿路感染。
Infection. 1991 Mar-Apr;19(2):124-6. doi: 10.1007/BF01645584.
9
Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities.长期护理机构中产超广谱β-内酰胺酶革兰氏阴性菌引起尿路感染的流行病学和遗传特征。
J Antimicrob Chemother. 2012 Dec;67(12):2982-7. doi: 10.1093/jac/dks300. Epub 2012 Aug 3.
10
[A double blind clinical trial of cefamandole and cefmetazole in complicated urinary tract infections].头孢孟多与头孢美唑治疗复杂性尿路感染的双盲临床试验
Jpn J Antibiot. 1983 Jan;36(1):129-49.